Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Down-regulation of P-gp expression and function after Mulberroside A treatment: potential role of protein kinase C and NF-kappa B.

Li Y, Huang L, Zeng X, Zhong G, Ying M, Huang M, Bi H.

Chem Biol Interact. 2014 Apr 25;213:44-50. doi: 10.1016/j.cbi.2014.02.004. Epub 2014 Feb 14.

PMID:
24530447
3.

Involvement of AP-1 and NF-κB in the up-regulation of P-gp in vinblastine resistant Caco-2 cells.

Chen Q, Bian Y, Zeng S.

Drug Metab Pharmacokinet. 2014;29(2):223-6. Epub 2013 Oct 1.

4.

[NF-κ B mediates the effect of glucosylceramide synthase on P-glycoprotein modulation in a drug-resistance leukemia cell line].

Zhang X, Xie K, Zou J, Li Y, Mu H, Zhang B, Xie P.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2014 Feb;31(1):34-8. doi: 10.3760/cma.j.issn.1003-9406.2014.01.008. Chinese.

PMID:
24510559
6.

Hyperammonemia enhances the function and expression of P-glycoprotein and Mrp2 at the blood-brain barrier through NF-κB.

Zhang J, Zhang M, Sun B, Li Y, Xu P, Liu C, Liu L, Liu X.

J Neurochem. 2014 Dec;131(6):791-802. doi: 10.1111/jnc.12944. Epub 2014 Sep 26.

7.

Increase in P-glycoprotein accompanied by activation of protein kinase Calpha and NF-kappaB p65 in the livers of rats with streptozotocin-induced diabetes.

Kameyama N, Arisawa S, Ueyama J, Kagota S, Shinozuka K, Hattori A, Tatsumi Y, Hayashi H, Takagi K, Wakusawa S.

Biochim Biophys Acta. 2008 May;1782(5):355-60. doi: 10.1016/j.bbadis.2008.02.005. Epub 2008 Mar 4.

9.

In vitro to in vivo evidence of the inhibitor characteristics of Schisandra lignans toward P-glycoprotein.

Liang Y, Zhou Y, Zhang J, Liu Y, Guan T, Wang Y, Xing L, Rao T, Zhou L, Hao K, Xie L, Wang GJ.

Phytomedicine. 2013 Aug 15;20(11):1030-8. doi: 10.1016/j.phymed.2013.04.005. Epub 2013 Jun 2.

PMID:
23731657
12.

Insulin regulates P-glycoprotein in rat brain microvessel endothelial cells via an insulin receptor-mediated PKC/NF-kappaB pathway but not a PI3K/Akt pathway.

Liu H, Yang H, Wang D, Liu Y, Liu X, Li Y, Xie L, Wang G.

Eur J Pharmacol. 2009 Jan 14;602(2-3):277-82. doi: 10.1016/j.ejphar.2008.11.026. Epub 2008 Nov 21.

PMID:
19049803
13.

Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation.

Kim HG, Hien TT, Han EH, Hwang YP, Choi JH, Kang KW, Kwon KI, Kim BH, Kim SK, Song GY, Jeong TC, Jeong HG.

Br J Pharmacol. 2011 Mar;162(5):1096-108. doi: 10.1111/j.1476-5381.2010.01101.x.

14.
15.
16.
17.

Effects of brain IKKβ gene silencing by small interfering RNA on P-glycoprotein expression and brain damage in the rat kainic acid-induced seizure model.

Yu N, Liu H, Zhang YF, Su LY, Liu XH, Li LC, Hao JB, Huang XJ, Di Q.

CNS Neurol Disord Drug Targets. 2014;13(4):661-72.

PMID:
24040792
18.

PSC833, cyclosporine analogue, downregulates MDR1 expression by activating JNK/c-Jun/AP-1 and suppressing NF-kappaB.

Bark H, Choi CH.

Cancer Chemother Pharmacol. 2010 May;65(6):1131-6. doi: 10.1007/s00280-009-1121-7. Epub 2009 Sep 18.

PMID:
19763573
20.

[Effect of tetrandrine on the doxorubicin-induced expression of mdr1 gene in K562 cells].

Lu XJ, Xu WL, Luo WJ, Wang FC, Chen QY.

Zhonghua Xue Ye Xue Za Zhi. 2008 Jul;29(7):468-71. Chinese.

PMID:
19035180
Items per page

Supplemental Content

Write to the Help Desk